Home Cart Sign in  
Chemical Structure| 528-58-5 Chemical Structure| 528-58-5

Structure of Cyanidin Chloride
CAS No.: 528-58-5

Chemical Structure| 528-58-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cyanidin chloride, a natural flavonoid isolated and purified from the peel of Glycinemax (L.) merr with significant antioxidant activity and vasoprotective effects and can interfere with inflammation, carcinogenesis, obesity, and diabetes.

Synonyms: IdB 1027; Cyanidin (chloride); Cyanidol chloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cyanidin Chloride

CAS No. :528-58-5
Formula : C15H11ClO6
M.W : 322.70
SMILES Code : OC1=CC2=[O+]C(C3=CC=C(O)C(O)=C3)=C(O)C=C2C(O)=C1.[Cl-]
Synonyms :
IdB 1027; Cyanidin (chloride); Cyanidol chloride
MDL No. :MFCD00017582
InChI Key :COAWNPJQKJEHPG-UHFFFAOYSA-N
Pubchem ID :68247

Safety of Cyanidin Chloride

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SW620 cells 10, 25, 50 µM 24, 48, 72 h To assess the direct inhibitory effect of CyCl on colon cancer cells. Results showed that CyCl treatment significantly decreased cell proliferation in a time- and dose-dependent manner in all colon cancer cells. Antioxidants (Basel). 2020 Mar 27;9(4):285
HT29 cells 10, 25, 50 µM 24, 48, 72 h To assess the direct inhibitory effect of CyCl on colon cancer cells. Results showed that CyCl treatment significantly decreased cell proliferation in a time- and dose-dependent manner in all colon cancer cells. Antioxidants (Basel). 2020 Mar 27;9(4):285
HCT116 cells 10, 25, 50 µM 24, 48, 72 h To assess the direct inhibitory effect of CyCl on colon cancer cells. Results showed that CyCl treatment significantly decreased cell proliferation in a time- and dose-dependent manner in all colon cancer cells. Antioxidants (Basel). 2020 Mar 27;9(4):285
HepG2 cells 4–256 μg/mL 24 h Assessed cell viability and LDH release, showing no toxicity at 256 μg/mL Virulence. 2022 Dec;13(1):1434-1445
HK-2 cells 50 µM 24 or 48 h To evaluate the effects of Cyanidin Chloride on cholesterol metabolism and inflammation in HK-2 cells under high-glucose conditions. Results showed that Cyanidin Chloride significantly enhanced cholesterol efflux and ABCA1 expression, and reduced high-glucose-induced proinflammatory cytokine expression. Drug Des Devel Ther. 2015 Sep 4;9:5099-113
H9C2 rat cardiomyocytes 200 μM 48 h CyCl significantly attenuated Dox-induced cell damage, reduced intracellular ROS and peroxynitrite accumulation, and inhibited ferroptosis and apoptosis-related cell death Adv Sci (Weinh). 2023 Oct;10(30):e2301136

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice MRSA-induced pneumonia model Subcutaneous injection 80 mg/kg Started 1 h post-infection, every 12 h for 96 h Assessed therapeutic effect on MRSA-induced pneumonia, showing survival rate increased from 10% to 50% Virulence. 2022 Dec;13(1):1434-1445
Mice Ethanol-induced gastric ulcer model Oral 5, 10, and 20 mg/kg Single dose, evaluated after 60 minutes To investigate the gastroprotective role of cyanidin chloride in an ethanol-induced gastric ulcer model and its underlying mechanisms. Results showed that cyanidin chloride exhibited gastroprotective activity at different doses in male and female mice, but the effective dose varied depending on sex. Pharmaceutics. 2022 Mar 4;14(3):565

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.10mL

0.62mL

0.31mL

15.49mL

3.10mL

1.55mL

30.99mL

6.20mL

3.10mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories